TORONTO, CANADA – In August, Lauren Compere attended the 16th International AIDS Conference in Toronto. The conference witnessed the launch of the ICCR report “Benchmarking AIDS: Evaluating Pharmaceutical Company Responses to the Public Health Crisis in Emerging Markets”. The report is based in part on information provided by Boston Common on European pharmaceutical companies, including GlaxoSmithKline and Novartis. The report finds room for improvement in efforts by pharmaceutical companies to develop new medicines to address neglected diseases and to provide the poor with access to existing medicines. The report also provides a scorecard for evaluating a company’s response to HIV/AIDS and to diseases that often accompany the virus, such as tuberculosis.
